Prothena Corp PLC (PRTA)
NASDAQ
Closed
Oct 12, 2026
Day's Range
8.3952 wk Range
7.73Overview - PRTA - Prothena Corp PLC
Key Statistics
Valuation
Enterprise Value
139.76M
P/E (Trailing)
-1.81
P/E (Forward)
-6.23
PEG Ratio
0.02
Price / Sales (TTM)
7.71
Price / Book
1.47
EV / EBITDA
-2.36
Profitability
Profit Margin
-80.67%
Operating Margin
-1,850.19%
Return on Assets
-10.66%
Return on Equity
-14.39%
Ownership
Shares Outstanding
51.74M
Float
34.11M
Short % of Shares Outstanding
18.79%
Held by Insiders
22.56%
Held by Institutions
93.27%
Price stats
Beta
-0.29
50-Day Avg
8.79
200-Day Avg
9.25
Dividends
Payout Ratio
0.00%
Frequency
Quarterly
Analyst Consensus
6 analysts
Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PRTA - Prothena Corp PLC
Peers - PRTA - Prothena Corp PLC
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- PRPRTANASDAQProthena Corporation plc420.96MMarket Cap-26.46%52-week change-1.81P/E (Trailing)-80.67%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - PRTA - Prothena Corp PLC
About
Prothena Corporation plc is a late-stage clinical biotechnology company focused on the discovery and development of novel therapies targeting protein dysregulation, particularly in neurodegenerative diseases and rare peripheral amyloid diseases. The company leverages deep expertise in the biology of misfolded proteins…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
